[Federal Register Volume 62, Number 26 (Friday, February 7, 1997)]
[Notices]
[Page 5835]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-3018]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Meeting of Commission on Dietary Supplement Labels

AGENCY: Office of Disease Prevention and Health Promotion.

ACTION: Commission on Dietary Supplement Labels: Notice of meeting #8.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) is providing 
notice of the eighth meeting of the Commission on Dietary Supplement 
Labels.

DATES: The Commission intends to hold its meetings on March 4, 1997 
from 1:00 p.m. to approximately 5:00 p.m., E.S.T., at the Omni Hotel, 
101 West Fayette Street, Baltimore, Maryland 21201. The meeting is open 
to the public; seating is limited.

FOR FURTHER INFORMATION CONTACT: Kenneth D. Fisher, Ph.D., Executive 
Director, Commission on Dietary Supplement Labels, Office of Disease 
Prevention and Health Promotion, Room 738G, Hubert H. Humphrey 
Building, 200 Independence Ave., SW., Washington, DC 20201, (202) 690-
7102.

SUPPLEMENTARY INFORMATION: Public Law 103-417, Section 12, authorized 
the establishment of a Commission on Dietary Supplement Labels whose 
seven members have been appointed by the President. The appointments to 
the Commission by the President and the establishment of the Commission 
by the Secretary of Health and Human Services reflect the commitment of 
the President and the Secretary to the development of a sound and 
consistent regulatory policy on labeling of dietary supplements.
    The Commission is charged with conducting a study and providing 
recommendations for regulation of label claims and statements for 
dietary supplements, including the use of supplemental literature in 
connection with their sale and, in addition, procedures for evaluation 
of label claims. The Commission is expected to evaluate how best to 
provide truthful, scientifically valid, and non-misleading information 
to consumers in order that they may make informed health care choices 
for themselves and their families. The Commission's study report may 
include recommendations on legislation, if appropriate and necessary.
    The Commission meeting agenda will include approval of minutes of 
the previous meeting, determination of the appropriateness and possible 
date for release of the Commission's final draft report for public 
review, review of certain materials drafted for possible inclusion in 
the Commission's report, and discussion of the process for review of 
Commission's final draft report. In addition, the Commission has 
requested further comments from several organizations that previously 
provided testimony and statements concerning (1) regulatory management 
of herbal remedies, and (2) possible use of third parties for 
evaluation of dietary supplement label claims. Oral statements and the 
required written statements of invited parties are to be restricted to 
additional views, data, and comments on these two topics. If time 
permits after the statements of the invited organizations, the Chair 
may allow brief oral statements from other interested parties and 
persons concerning these two topics.
    The meeting is open to the public; however seating is limited. If 
you will require a sign language interpreter, please call Sandra 
Saunders (202) 690-7102 by 4:30 p.m. E.S.T. on February 24, 1997.

    Dated: January 30, 1997.
Linda D. Meyers,
Acting Deputy Director, Office of Disease Prevention and Health 
Promotion, Department of Health and Human Services.
[FR Doc. 97-3018 Filed 2-6-97; 8:45 am]
BILLING CODE 4160-17-M